Akebia Therapeutics shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in Akebia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akebia Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Akebia Therapeutics by Deutsche Bank Aktiengesellschaft
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $427k | 157k | 2.73 |
| 2025-06-30 | $479k | 132k | 3.64 |
| 2025-03-31 | $309k | 161k | 1.92 |
| 2024-12-31 | $344k | 181k | 1.90 |
| 2024-09-30 | $146k | 110k | 1.32 |
| 2022-03-31 | $83k | 108k | 0.77 |
| 2021-12-31 | $275k | 119k | 2.30 |
| 2021-09-30 | $354k | 115k | 3.07 |
| 2021-06-30 | $421k | 110k | 3.84 |
| 2021-03-31 | $378k | 111k | 3.39 |
| 2020-12-31 | $326k | 120k | 2.72 |
| 2020-09-30 | $1.1M | 441k | 2.55 |
| 2020-06-30 | $3.7M | 276k | 13.51 |
| 2020-03-31 | $1.8M | 237k | 7.59 |
| 2019-12-31 | $504k | 80k | 6.30 |
| 2019-09-30 | $180k | 46k | 3.90 |
| 2019-06-30 | $715k | 150k | 4.78 |
| 2019-03-31 | $750k | 98k | 7.68 |
| 2018-12-31 | $956k | 173k | 5.52 |
| 2018-09-30 | $2.2M | 258k | 8.59 |
| 2018-06-30 | $1.4M | 143k | 9.95 |
| 2018-03-31 | $4.4M | 461k | 9.52 |
| 2017-12-31 | $2.4M | 162k | 14.87 |
| 2017-09-30 | $4.0M | 211k | 18.79 |
| 2017-06-30 | $3.9M | 275k | 14.33 |
| 2017-03-31 | $190k | 21k | 9.00 |
| 2016-12-31 | $254k | 25k | 10.33 |
| 2016-09-30 | $125k | 14k | 9.00 |
| 2016-06-30 | $199k | 27k | 7.33 |
| 2016-03-31 | $173k | 19k | 9.00 |
| 2015-12-31 | $257k | 20k | 12.67 |
| 2015-09-30 | $153k | 16k | 9.33 |
| 2015-06-30 | $1.7M | 171k | 10.00 |
| 2015-03-31 | $0 | 4.4k | 0.00 |
| 2014-12-31 | $0 | 10k | 0.00 |
| 2014-09-30 | $1.0k | 72 | 13.89 |
| 2014-06-30 | $999 | 39 | 25.64 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft